Anika Therapeutics (ANIK) Balance Sheet: Assets & Liabilities

Anika Therapeutics (ANIK) Balance Sheet

As of Dec 31, 2025 (end of fiscal 2025), Anika Therapeutics reported total assets of $190.27M and total liabilities of $46.80M. Shareholders' equity was $143.47M, down 6.8% from $153.99M a year earlier. Total debt stood at $26.25M against $57.48M in cash and short-term investments, a net cash position of $31.23M. That puts debt-to-equity at 0.18, compared with 0.17 a year earlier.

Anika Therapeutics Balance Sheet Analysis

Values in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Anika Therapeutics, Inc. (ANIK) - Annual data in millions USD
Breakdown	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period ending	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018	Dec 2017
Current Assets
Cash and Cash Equivalents	57.48	55.63	68.74	86.33	94.39	95.82	157.46	89.04	133.26
Short-Term Investments	0.00	0.00	0.00	0.00	0.00	2.50	27.48	69.97	24.00
Cash & Short-Term Investments	57.48	55.63	68.74	86.33	94.39	98.32	184.94	159.01	157.26
Accounts Receivable	23.69	23.59	26.36	34.63	29.84	24.10	23.08	20.78	23.83
Inventory	18.79	23.81	24.43	39.77	36.01	46.21	22.00	21.30	22.04
Other Current Assets	3.40	10.62	43.78	8.83	8.29	8.75	4.29	1.85	3.21
Total Current Assets	103.36	113.65	163.31	169.55	168.53	177.38	234.31	202.94	206.33
Non-Current Assets
Property, Plant & Equipment (Net)	66.26	64.68	65.00	78.98	68.56	73.23	73.65	54.11	56.18
Long-Term Investments	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-7.21	-4.77
Goodwill	8.05	7.13	7.57	7.34	7.78	8.41	7.69	7.85	8.22
Intangible Assets	1.65	2.49	2.58	74.60	82.38	91.16	7.59	9.19	10.64
Other Non-Current Assets	10.95	13.62	32.18	17.22	20.29	15.42	7.48	4.90	1.25
Total Non-Current Assets	86.91	89.09	107.32	179.58	179.01	188.22	96.40	76.05	76.29
Total Assets	190.27	202.74	270.63	349.13	347.54	365.61	330.71	278.99	282.62
Current Liabilities
Accounts Payable	6.04	5.62	6.19	9.07	7.63	8.98	3.83	3.14	6.75
Short-Term Debt	2.05	1.92	1.83	2.07	1.71	1.59	1.14	0.00	0.00
Accrued Liabilities	15.87	13.57	14.07	4.65	6.61	13.21	-	-	-
Other Current Liabilities	13.82	15.71	10.80	15.96	4.32	13.09	11.30	7.76	6.33
Total Current Liabilities	21.91	23.31	31.06	27.91	29.80	36.87	16.28	11.29	13.07
Non-Current Liabilities
Long-Term Debt	24.20	24.01	25.92	28.82	19.24	20.88	21.37	0.00	0.00
Deferred Tax Liabilities	0.00	0.00	0.00	6.44	10.16	11.90	4.33	3.54	5.39
Other Non-Current Liabilities	0.70	1.43	1.39	0.40	1.26	23.56	0.36	0.55	0.66
Total Non-Current Liabilities	24.90	25.45	27.31	35.65	30.66	56.34	26.06	4.09	6.05
Total Liabilities	46.81	48.75	58.37	63.57	60.45	93.21	42.33	15.38	19.13
Stockholders' Equity
Common Stock	0.14	0.14	0.15	0.15	0.14	0.14	0.14	0.14	0.15
Retained Earnings	60.79	71.67	128.05	210.72	225.58	221.44	245.43	218.23	199.51
Accumulated Other Comprehensive Income	-4.96	-6.78	-5.94	-6.44	-5.72	-4.54	-5.90	-5.53	-4.78
Additional Paid-in Capital	87.50	88.96	90.01	81.14	67.08	55.36	48.71	50.76	68.62
Shares Outstanding	13.89	14.42	14.66	14.63	14.44	-	-	-	-
Total Stockholders' Equity	143.47	153.99	212.27	285.56	287.09	272.40	288.38	263.61	263.49
Total Liabilities & Equity	190.27	202.74	270.63	349.13	347.54	365.61	330.71	278.99	282.62

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Anika Therapeutics Balance Sheet

How much debt does Anika Therapeutics have?

Anika Therapeutics had total debt of $26.25M as of Dec 31, 2025, against $57.48M in cash and short-term investments. Its debt-to-equity ratio was 0.18. Total debt was $25.93M a year earlier.

What are Anika Therapeutics's total assets?

Anika Therapeutics reported total assets of $190.27M as of Dec 31, 2025, down 6.2% from $202.74M a year earlier. Total liabilities were $46.80M.

What is Anika Therapeutics's shareholders' equity?

Anika Therapeutics's shareholders' equity was $143.47M as of Dec 31, 2025, or about $10.33 of book value per share.

What is the debt-to-equity ratio?

The debt-to-equity ratio divides a company's total debt by its shareholders' equity. It shows how much of the business is financed with borrowed money; normal levels vary widely by industry. Full definition